Baker Bros. Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.4M | Hold |
|
|||||
|
2025
Q1 | $61.4M | Hold |
|
|||||
|
2024
Q4 | $80.7M | Hold |
|
|||||
|
2024
Q3 | $71.6M | Hold |
|
|||||
|
2024
Q2 | $81.5M | Hold |
|
|||||
|
2024
Q1 | $125M | Buy |
|
|||||
|
2023
Q4 | $131M | Buy |
|
|||||
|
2023
Q3 | $95.5M | Buy |
|
|||||
|
2023
Q2 | $106M | Buy |
|
|||||
|
2023
Q1 | $78.8M | Hold |
|
|||||
|
2022
Q4 | $106M | Hold |
|
|||||
|
2022
Q3 | $103M | Hold |
|
|||||
|
2022
Q2 | $111M | Hold |
|
|||||
|
2022
Q1 | $102M | Hold |
|
|||||
|
2021
Q4 | $149M | Hold |
|
|||||
|
2021
Q3 | $209M | Hold |
|
|||||
|
2021
Q2 | $230M | Hold |
|
|||||
|
2021
Q1 | $355M | Hold |
|
|||||
|
2020
Q4 | $421M | Buy |
|